What is a practical basal‑bolus insulin regimen for an adult with insulin‑requiring diabetes (type 1 or insulin‑treated type 2)?

Basal-Bolus Insulin Regimen for Insulin-Requiring Diabetes

For adults with insulin-requiring diabetes (type 1 or insulin-treated type 2), initiate a basal-bolus regimen with approximately 50% of the total daily dose as long-acting basal insulin once daily and 50% as rapid-acting prandial insulin divided equally before three meals. 1, 2, 3

Initial Dosing Strategy

Type 1 Diabetes

• Start with a total daily dose of 0.5 units/kg/day for metabolically stable adults with type 1 diabetes 1, 2, 4
• Allocate 40-50% as basal insulin (glargine, detemir, or degludec) administered once daily, typically at bedtime 1, 2, 5
• Allocate 50-60% as prandial insulin (lispro, aspart, or glulisine) divided among three meals 1, 2, 5
• For a 70 kg patient, this translates to approximately 35 units total: 17-18 units basal and 17-21 units prandial (≈6-7 units per meal) 2
• Higher doses up to 1.0-1.5 units/kg/day may be required during puberty, pregnancy, or acute illness 1, 2, 4

Type 2 Diabetes

• For insulin-naïve patients with moderate hyperglycemia, start with 10 units of basal insulin once daily or 0.1-0.2 units/kg/day 1, 2
• For severe hyperglycemia (HbA1c ≥9%, glucose ≥300 mg/dL, or symptomatic), initiate basal-bolus immediately with 0.3-0.5 units/kg/day total, split 50% basal and 50% prandial 1, 2, 3
• Continue metformin at maximum tolerated dose (up to 2000-2550 mg daily) unless contraindicated, as this reduces insulin requirements by 20-30% 1, 2

High-Risk Populations

• For elderly patients (>65 years), those with renal impairment (eGFR <60 mL/min), or poor oral intake, start with 0.1-0.25 units/kg/day to minimize hypoglycemia risk 1, 2, 3, 5
• For hospitalized patients on high-dose home insulin (≥0.6 units/kg/day), reduce the total daily dose by 20% upon admission 1, 2

Insulin Administration Timing

Basal Insulin

• Administer long-acting basal insulin once daily at the same time each day, typically at bedtime (20:00 hours) 1, 2
• Insulin glargine, detemir, and degludec are preferred over NPH due to lower hypoglycemia risk 1, 6, 7, 4
• Some patients with type 1 diabetes may require twice-daily basal dosing if once-daily administration fails to provide 24-hour coverage 2

Prandial Insulin

• Inject rapid-acting insulin 0-15 minutes before meals (ideally immediately before eating) for optimal postprandial control 1, 2, 7
• Rapid-acting analogs (lispro, aspart, glulisine) are preferred over regular human insulin due to better postprandial control and lower hypoglycemia risk 1, 7, 4
• Never administer rapid-acting insulin at bedtime as a sole correction dose, as this markedly increases nocturnal hypoglycemia risk 1, 2

Titration Protocols

Basal Insulin Titration

• Increase basal dose by 2 units every 3 days if fasting glucose is 140-179 mg/dL 1, 2
• Increase basal dose by 4 units every 3 days if fasting glucose is ≥180 mg/dL 1, 2
• Target fasting glucose: 80-130 mg/dL 1, 2
• If unexplained hypoglycemia (<70 mg/dL) occurs, reduce the dose by 10-20% immediately 1, 2

Prandial Insulin Titration

• Adjust each meal dose by 1-2 units (10-15%) every 3 days based on 2-hour postprandial glucose 1, 2
• Target postprandial glucose: <180 mg/dL 1, 2
• Use carbohydrate-to-insulin ratio: 450 ÷ total daily dose for rapid-acting analogs (e.g., 450 ÷ 45 units = 1:10 ratio) 1, 2

Critical Threshold: Recognizing Over-Basalization

• Stop escalating basal insulin when the dose exceeds 0.5 units/kg/day and approaches 1.0 units/kg/day without achieving glycemic targets 1, 2, 3
• Clinical signals of over-basalization include:
  • Basal dose >0.5 units/kg/day 1, 2
  • Bedtime-to-morning glucose differential ≥50 mg/dL 1, 2
  • Episodes of hypoglycemia despite overall hyperglycemia 1, 2
  • High glucose variability 1, 2
• At this threshold, add or intensify prandial insulin rather than continuing basal escalation 1, 2, 3

Stepwise Intensification Approach

Starting with Basal-Only

• For type 2 diabetes with mild-to-moderate hyperglycemia, begin with basal insulin alone 1, 8
• If HbA1c remains above target after 3-6 months despite optimized basal insulin, add prandial coverage 1, 2, 8

Basal-Plus Strategy

• Start by adding 4 units of rapid-acting insulin before the largest meal or 10% of the current basal dose 1, 2, 3, 8
• Titrate this single prandial dose by 1-2 units every 3 days based on postprandial glucose 1, 2, 8
• If glycemic targets are still not met, sequentially add prandial insulin to the second and third meals 3, 8

Correction (Supplemental) Insulin

• Add 2 units of rapid-acting insulin for pre-meal glucose >250 mg/dL 1, 2
• Add 4 units for pre-meal glucose >350 mg/dL 1, 2
• Correction insulin must supplement—not replace—scheduled basal and prandial doses 1, 2
• For individualized correction, calculate insulin sensitivity factor: 1500 ÷ total daily dose; correction dose = (current glucose - target glucose) ÷ ISF 1, 2

Monitoring Requirements

• Daily fasting glucose during titration to guide basal adjustments 1, 2
• Pre-meal glucose before each meal to calculate correction doses 1, 2
• 2-hour postprandial glucose after each meal to assess prandial adequacy 1, 2
• Bedtime glucose to evaluate overall daily pattern 1, 2
• HbA1c every 3 months during intensive titration 1, 2
• For patients on intensive regimens, 6-10 glucose checks per day may be needed (pre-meal, bedtime, occasional postprandial, pre-exercise) 2

Expected Clinical Outcomes

• With properly implemented basal-bolus therapy, approximately 68% of patients achieve mean glucose <140 mg/dL, compared with 38% using inadequate regimens 1, 2, 5
• HbA1c reductions of 2-3% (or 3-4% in severe hyperglycemia) are achievable over 3-6 months 1, 2
• Properly executed basal-bolus regimens do not increase overall hypoglycemia incidence compared with inadequate approaches 1, 2, 5

Hypoglycemia Management

• Treat any glucose <70 mg/dL immediately with 15 grams of fast-acting carbohydrate (4 glucose tablets or 4 oz juice) 1, 2, 4
• Recheck glucose in 15 minutes and repeat treatment if needed 1, 2
• If hypoglycemia occurs without obvious cause, reduce the implicated insulin dose by 10-20% before the next administration 1, 2
• Provide comprehensive patient education on hypoglycemia recognition, treatment, proper injection technique, site rotation, and sick-day management 1, 2, 4

Common Pitfalls to Avoid

• Never use sliding-scale insulin as monotherapy; major diabetes guidelines condemn this reactive approach as it achieves target glucose in only 38% of patients versus 68% with scheduled basal-bolus therapy 1, 2, 5
• Do not delay adding prandial insulin when basal insulin exceeds 0.5 units/kg/day without achieving targets 1, 2, 3
• Do not continue escalating basal insulin beyond 0.5-1.0 units/kg/day without addressing postprandial hyperglycemia, as this leads to over-basalization with increased hypoglycemia risk 1, 2, 3
• Do not discontinue metformin when starting insulin in type 2 diabetes unless contraindicated, as this leads to higher insulin requirements and more weight gain 1, 2
• Never give rapid-acting insulin at bedtime as a sole correction dose, as this markedly increases nocturnal hypoglycemia risk 1, 2
• Do not use premixed insulin in hospitalized patients, as randomized trials show a 64% hypoglycemia rate versus 24% with basal-bolus regimens 2, 5

Alternative: Insulin Pump Therapy

• For patients not meeting glycemic targets with multiple daily injections or those with frequent hypoglycemia, consider continuous subcutaneous insulin infusion (CSII) 1, 7, 4
• In pump therapy, basal delivery accounts for 40-60% of total daily dose, with the remainder as mealtime and correction boluses 1, 2, 9
• Most patients with type 2 diabetes require only one or two basal rates on pump therapy 9
• Continuous glucose monitoring with automated insulin delivery systems result in less hypoglycemia and improved HbA1c levels 4